• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Austral J Vet Sci . Replication kinetics of novel swine influenza A viruses: an approach to vaccine production

tetano

Editor, Senior Moderator
Austral J Vet Sci


. 2024 May;56(2):85-90.
doi: 10.4206/ajvs.562.01. Epub 2024 May 22. Replication kinetics of novel swine influenza A viruses: an approach to vaccine production

Rodrigo Tapia[SUP] 1 2 [/SUP], Rafael Medina[SUP] 3 4 5 [/SUP], Víctor Neira[SUP] 2 [/SUP]



Affiliations
Abstract

Novel swine Influenza A viruses (IAVs) have been described in South America. The objective of this study was to evaluate the replication kinetics of novel swine IAVs as a first step in vaccine production. Different swine IAV lineages (H1N1, H1N2, and H3N2), infection doses (MOI: 1, 0.1, 0.01, 0.001, 0.0001, and 0.00001), harvest times (every 12 h), and substrates (MDCK and Vero cells) were used. For all IAV strains, MDCK cells were the most efficient substrate, generating titers of ≥128 HAU/50 μL with an MOI of 0.00001 at 60 h post-infection. These data may be useful in vaccine-producing laboratories.

Keywords: Influenza A virus; MDCK cells; Vero cells; antigen; swine; vaccine.

 
Back
Top Bottom